{
  "claim": "Cancer can cause excess adrenaline production.",
  "Args": {
    "A1": {
      "supporting": {
        "id": "A1",
        "cate": "P",
        "text": "Certain tumors, such as pheochromocytomas, are known to secrete excessive adrenaline and other catecholamines, directly linking cancer to adrenaline overproduction."
      },
      "attacks": [
        {
          "id": "A1",
          "text": "Certain tumors, such as pheochromocytomas, are known to secrete excessive adrenaline and other catecholamines, directly linking cancer to adrenaline overproduction.",
          "cate": "P",
          "confidence": 0.92,
          "attacks": {}
        },
        {
          "id": "B1",
          "text": "Pheochromocytomas are rare, accounting for less than 0.2% of all cancers, so they are not representative of most cancers.",
          "confidence": 0.85,
          "attacks": {
            "A1": 0.8
          }
        },
        {
          "id": "C1",
          "text": "Even though pheochromocytomas are rare, their well-documented mechanism of adrenaline overproduction still validates the general claim that cancer can cause excess adrenaline.",
          "confidence": 0.75,
          "attacks": {
            "B1": 0.7
          }
        },
        {
          "id": "B2",
          "text": "Non-pheochromocytoma cancers rarely cause adrenaline overproduction, making the claim misleading for the majority of cancer cases.",
          "confidence": 0.78,
          "attacks": {
            "A1": 0.65
          }
        },
        {
          "id": "C2",
          "text": "Some non-pheochromocytoma cancers (e.g., neuroblastomas) can also disrupt adrenal or sympathetic nervous system function, leading to adrenaline overproduction.",
          "confidence": 0.68,
          "attacks": {
            "B2": 0.6
          }
        }
      ]
    },
    "A2": {
      "supporting": {
        "id": "A2",
        "cate": "P",
        "text": "Neuroendocrine tumors can disrupt normal hormone regulation, leading to abnormal adrenaline secretion as part of paraneoplastic syndromes."
      },
      "attacks": [
        {
          "id": "A2",
          "text": "Neuroendocrine tumors can disrupt normal hormone regulation, leading to abnormal adrenaline secretion as part of paraneoplastic syndromes.",
          "cate": "P",
          "confidence": 0.85,
          "attacks": {}
        },
        {
          "id": "B1",
          "text": "Neuroendocrine tumors are rare, accounting for less than 2% of all cancers, making this mechanism an unlikely general explanation for excess adrenaline production in most cancer patients.",
          "confidence": 0.75,
          "attacks": {
            "A2": 0.65
          }
        },
        {
          "id": "B2",
          "text": "Many neuroendocrine tumors are non-functional and do not secrete hormones, meaning they would not necessarily lead to excess adrenaline production even if present.",
          "confidence": 0.8,
          "attacks": {
            "A2": 0.7
          }
        },
        {
          "id": "C1",
          "text": "Even rare neuroendocrine tumors are disproportionately represented in cases of paraneoplastic syndromes, making them clinically significant when they do occur.",
          "confidence": 0.78,
          "attacks": {
            "B1": 0.75,
            "B2": 0.6
          }
        },
        {
          "id": "B3",
          "text": "Stress responses to cancer diagnosis and treatment are far more common causes of excess adrenaline than direct tumor effects.",
          "confidence": 0.9,
          "attacks": {
            "A2": 0.8
          }
        },
        {
          "id": "C2",
          "text": "Paraneoplastic syndromes often present before cancer diagnosis, making them important early indicators distinct from treatment-related stress responses.",
          "confidence": 0.82,
          "attacks": {
            "B3": 0.7
          }
        }
      ]
    },
    "A3": {
      "supporting": {
        "id": "A3",
        "cate": "P",
        "text": "Metastatic cancers affecting the adrenal glands may interfere with their function, potentially causing dysregulated adrenaline release."
      },
      "attacks": [
        {
          "id": "A3",
          "text": "Metastatic cancers affecting the adrenal glands may interfere with their function, potentially causing dysregulated adrenaline release.",
          "cate": "P",
          "confidence": 0.75,
          "attacks": {}
        },
        {
          "id": "B1",
          "text": "Most metastatic cancers do not target the adrenal glands, making this a rare scenario.",
          "confidence": 0.65,
          "attacks": {
            "A3": 0.6
          }
        },
        {
          "id": "B2",
          "text": "Adrenal dysfunction from cancer is more likely to cause hormone deficiency rather than excess adrenaline.",
          "confidence": 0.7,
          "attacks": {
            "A3": 0.75
          }
        },
        {
          "id": "C1",
          "text": "Even rare cases are clinically significant when they occur, especially in metastatic cancer patients.",
          "confidence": 0.8,
          "attacks": {
            "B1": 0.85
          }
        },
        {
          "id": "C2",
          "text": "Some adrenal metastases can cause hypersecretion by stimulating residual functional tissue.",
          "confidence": 0.72,
          "attacks": {
            "B2": 0.7
          }
        }
      ]
    },
    "A4": {
      "supporting": {
        "id": "A4",
        "cate": "P",
        "text": "Chronic stress from cancer progression can activate the sympathetic nervous system, indirectly increasing adrenaline production as a physiological response."
      },
      "attacks": [
        {
          "id": "A4",
          "text": "Chronic stress from cancer progression can activate the sympathetic nervous system, indirectly increasing adrenaline production as a physiological response.",
          "cate": "P",
          "confidence": 0.85,
          "attacks": {}
        },
        {
          "id": "B1",
          "text": "Not all cancer types or stages cause chronic stress significant enough to activate the sympathetic nervous system.",
          "confidence": 0.72,
          "attacks": {
            "A4": 0.65
          }
        },
        {
          "id": "C1",
          "text": "Even in less aggressive cancers, localized pain or psychological distress can still trigger stress responses.",
          "confidence": 0.68,
          "attacks": {
            "B1": 0.7
          }
        },
        {
          "id": "B2",
          "text": "Adrenal medulla dysfunction due to cancer metastasis is a more direct cause of excess adrenaline than stress-induced mechanisms.",
          "confidence": 0.8,
          "attacks": {
            "A4": 0.6
          }
        },
        {
          "id": "C2",
          "text": "Stress-induced adrenaline production and metastasis-related dysfunction often co-occur in advanced cancer patients.",
          "confidence": 0.75,
          "attacks": {
            "B2": 0.55
          }
        }
      ]
    },
    "A5": {
      "supporting": {
        "id": "A5",
        "cate": "P",
        "text": "Some cancers produce adrenocorticotropic hormone (ACTH) ectopically, stimulating the adrenal glands to overproduce adrenaline and related hormones."
      },
      "attacks": [
        {
          "id": "A5",
          "text": "Some cancers produce adrenocorticotropic hormone (ACTH) ectopically, stimulating the adrenal glands to overproduce adrenaline and related hormones.",
          "cate": "P",
          "confidence": 0.85,
          "attacks": {}
        },
        {
          "id": "B1",
          "text": "Ectopic ACTH production is rare, occurring in less than 1% of all cancer cases.",
          "confidence": 0.75,
          "attacks": {
            "A5": 0.65
          }
        },
        {
          "id": "C1",
          "text": "Even in rare cases, ectopic ACTH production is clinically significant and well-documented in medical literature.",
          "confidence": 0.82,
          "attacks": {
            "B1": 0.8
          }
        },
        {
          "id": "B2",
          "text": "Most adrenaline excess cases are caused by pheochromocytomas or adrenal tumors, not ectopic ACTH production.",
          "confidence": 0.78,
          "attacks": {
            "A5": 0.7
          }
        },
        {
          "id": "C2",
          "text": "While adrenal tumors are more common, the claim specifically addresses cancer-induced adrenaline excess, which includes ectopic ACTH production.",
          "confidence": 0.8,
          "attacks": {
            "B2": 0.75
          }
        }
      ]
    }
  }
}